Lilly antibody drug fails in a COVID-19 study; others go on

U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with COVID-19 because it doesn’t seem to be helping them.

Read more…

Please follow and like us: